Phoenix Wealth Advisors Bristol Myers Squibb CO Transaction History

Phoenix Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $79,104 - $92,217	-1,475 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $2,958 - $3,465	-50 Reduced 3.28%	1,475 $87,000
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $5,162 - $5,806	87 Added 6.05%	1,525 $96,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $83,030 - $94,088	1,438 New	1,438 $89,000

2,552

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.